These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 28913842

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interobserver variability in Gleason histological grading of prostate cancer.
    Ozkan TA, Eruyar AT, Cebeci OO, Memik O, Ozcan L, Kuskonmaz I.
    Scand J Urol; 2016 Dec; 50(6):420-424. PubMed ID: 27416104
    [Abstract] [Full Text] [Related]

  • 7. A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States.
    Oyama T, Allsbrook WC, Kurokawa K, Matsuda H, Segawa A, Sano T, Suzuki K, Epstein JI.
    Arch Pathol Lab Med; 2005 Aug; 129(8):1004-10. PubMed ID: 16048389
    [Abstract] [Full Text] [Related]

  • 8. Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists.
    Allsbrook WC, Mangold KA, Johnson MH, Lane RB, Lane CG, Amin MB, Bostwick DG, Humphrey PA, Jones EC, Reuter VE, Sakr W, Sesterhenn IA, Troncoso P, Wheeler TM, Epstein JI.
    Hum Pathol; 2001 Jan; 32(1):74-80. PubMed ID: 11172298
    [Abstract] [Full Text] [Related]

  • 9. Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist.
    Allsbrook WC, Mangold KA, Johnson MH, Lane RB, Lane CG, Epstein JI.
    Hum Pathol; 2001 Jan; 32(1):81-8. PubMed ID: 11172299
    [Abstract] [Full Text] [Related]

  • 10. A grading dilemma; Gleason scoring system: Are we sufficiently compatible? A multi center study.
    Dere Y, Çelik ÖI, Çelik SY, Ekmekçi S, Evcim G, Pehlivan F, Ağalar A, Deliktaş H, Çulhacı N.
    Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S25-S29. PubMed ID: 32108622
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Interobserver reproducibility of Gleason grading in prostate biopsy samples].
    Bori R, Salamon F, Móczár C, Cserni G.
    Orv Hetil; 2013 Aug 04; 154(31):1219-25. PubMed ID: 23895990
    [Abstract] [Full Text] [Related]

  • 14. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI, Amin MB, Reuter VE, Humphrey PA.
    Am J Surg Pathol; 2017 Apr 04; 41(4):e1-e7. PubMed ID: 28177964
    [Abstract] [Full Text] [Related]

  • 15. Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade.
    Fanning DM, Kay E, Fan Y, Fitzpatrick JM, Watson RW.
    BJU Int; 2010 Mar 04; 105(5):631-5. PubMed ID: 19732053
    [Abstract] [Full Text] [Related]

  • 16. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
    Flood TA, Schieda N, Keefe DT, Breau RH, Morash C, Hogan K, Belanger EC, Mai KT, Robertson SJ.
    Virchows Arch; 2016 Sep 04; 469(3):313-9. PubMed ID: 27394432
    [Abstract] [Full Text] [Related]

  • 17. Bayesian belief network for the Gleason patterns in prostatic adenocarcinoma: development of a diagnostic decision support system for educational purposes.
    Montironi R, Ball RY, Griffiths DF, Grigor K, Harnden PM, Jarmulowicz M, McWilliam LJ, Moseley RP, Parkinson MC, Santinelli A, Moss SM, Melia JW.
    Anal Quant Cytol Histol; 2008 Feb 04; 30(1):8-15. PubMed ID: 18459582
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.